Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2015-01-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real Life Weight Bearing After Tibial Fractures
NCT03166267
Fracture Monitor - Femur
NCT05410587
Fixation Stability and Bony Healing Following Open Wedge High Tibial Osteotomy
NCT00284596
Clinical Follow-up to Evaluate the Clinical Usefulness of Gentamicin-coated Titanium Nails in Tibia Fractures
NCT01282294
Mobile Monitoring of Fracture Healing
NCT02534259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
20 patients having received an AO large external fixator at the tibia will be equipped with a data logger device (AO Fracture Monitor) attached post-operation to a connection rod of the external fixator. The device continuously measures deformation of the fixator frame due to weight bearing for up to 4 months by means of a strain gauge. Several parameters are calculated from the recorded change in the strain signal and are stored at a regular interval. Data is collected from the AO Fracture Monitor at follow-up visits of the patient by wireless data transfer. Together with additional variables such as treatment details, fracture healing and pain reported by the patient, the collected data is used to build up a database. Data from the AO Fracture Monitor will be correlated with patient data to investigate the relevance and reliability of the data derived from the AO Fracture Monitor.
In this phase, the study does not imply changes on the operational treatment, nor does it allow for therapeutic consequences based on the derived data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SmartFix
AO Fracture Monitor attached postoperatively to a connection rod of the external fixator. The device continuously measures deformation of the fixator frame due to weight bearing for up to 4 months by means of a strain gauge.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Femoral or tibial fracture (AO 41-43)
* External fracture fixation with AO large external fixator
* Capable of at least partial weight-bearing
* Informed consent obtained, i.e.:
* Ability to understand the content of the patient information/Informed Consent Form (ICF)
* Willingness and ability to participate in the Focused Registry according to the Registry Plan (RP)
* Signed and dated Ethics Committee (EC) approved written informed consent
Exclusion Criteria
* Joint-bridging external fixation
* Any not medically managed severe systemic disease
* Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
* Pregnancy or nursing mother
* Emergency patient
* Prisoner
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AO Clinical Investigation and Publishing Documentation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dankward Höntzsch, Professor
Role: PRINCIPAL_INVESTIGATOR
Berufsgenossenschaftliche Unfallklinik Tübingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Berufsgenossenschaftliche Unfallklinik
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FRSmartFix
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.